TY - JOUR
T1 - The association between PFOA, PFOS and serum lipid levels in adolescents
AU - Geiger, Sarah Dee
AU - Xiao, Jie
AU - Ducatman, Alan
AU - Frisbee, Stephanie
AU - Innes, Kim
AU - Shankar, Anoop
N1 - Funding Information:
This publication was made possible by Grant numbers 5T32 HL090610-04, 1R01ES021825-01 and 5R03ES018888-02 from the National Institutes of Health.
PY - 2014/3
Y1 - 2014/3
N2 - Introduction: Dyslipidemia in children is associated with accelerated atherosclerosis and earlier cardiovascular disease development. Environmental exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) have been shown to be associated with dyslipidemia in adults. However, there are few general population studies examining this association in children or adolescents. In this context, we examined the association between serum PFOA and PFOS levels and dyslipidemia in a nationally representative sample of US adolescents. Methods: A cross-sectional study was performed on 815 participants ≤18. years of age from the National Health and Nutrition Examination Survey 1999-2008. The main outcome was dyslipidemia, defined as total cholesterol >170. mg/dL, low-density lipoprotein cholesterol (LDL-C) >110. mg/dL, high-density lipoprotein cholesterol (HDL-C) <40. mg/dL or triglycerides >150. mg/dL. Results: We found that serum PFOA and PFOS were positively associated with high total cholesterol and LDL-C, independent of age, sex, race-ethnicity, body mass index, annual household income, physical activity and serum cotinine levels. Compared to subjects in quartile 1 (referent), the multivariable-adjusted odds ratio (95% confidence interval) for high total cholesterol among children in quartile 4 was 1.16 (1.05-2.12) for PFOA and 1.53 (1.11-1.64) for PFOS. PFOA and PFOS were not significantly associated with abnormal HDL-C and triglyceride levels. Discussion: Our findings indicate that serum PFOA and PFOS are significantly associated with dyslipidemia in adolescents, even at the lower "background" exposure levels of the US general population.
AB - Introduction: Dyslipidemia in children is associated with accelerated atherosclerosis and earlier cardiovascular disease development. Environmental exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) have been shown to be associated with dyslipidemia in adults. However, there are few general population studies examining this association in children or adolescents. In this context, we examined the association between serum PFOA and PFOS levels and dyslipidemia in a nationally representative sample of US adolescents. Methods: A cross-sectional study was performed on 815 participants ≤18. years of age from the National Health and Nutrition Examination Survey 1999-2008. The main outcome was dyslipidemia, defined as total cholesterol >170. mg/dL, low-density lipoprotein cholesterol (LDL-C) >110. mg/dL, high-density lipoprotein cholesterol (HDL-C) <40. mg/dL or triglycerides >150. mg/dL. Results: We found that serum PFOA and PFOS were positively associated with high total cholesterol and LDL-C, independent of age, sex, race-ethnicity, body mass index, annual household income, physical activity and serum cotinine levels. Compared to subjects in quartile 1 (referent), the multivariable-adjusted odds ratio (95% confidence interval) for high total cholesterol among children in quartile 4 was 1.16 (1.05-2.12) for PFOA and 1.53 (1.11-1.64) for PFOS. PFOA and PFOS were not significantly associated with abnormal HDL-C and triglyceride levels. Discussion: Our findings indicate that serum PFOA and PFOS are significantly associated with dyslipidemia in adolescents, even at the lower "background" exposure levels of the US general population.
KW - Dyslipidemia
KW - Lipids
KW - Perfluoroalkyl chemicals
KW - Perfluorooctane sulfonate
KW - Perfluorooctanoic acid
KW - PFC
UR - http://www.scopus.com/inward/record.url?scp=84893013767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84893013767&partnerID=8YFLogxK
U2 - 10.1016/j.chemosphere.2013.10.005
DO - 10.1016/j.chemosphere.2013.10.005
M3 - Article
C2 - 24238303
AN - SCOPUS:84893013767
SN - 0045-6535
VL - 98
SP - 78
EP - 83
JO - Chemosphere
JF - Chemosphere
ER -